-
s CD44 as the Target Site for Hyaluronic Acid in Favor of Colitis Management
- Source: Letters in Drug Design & Discovery, Volume 21, Issue 12, Sep 2024, p. 2189 - 2194
-
- 01 Sep 2024
- Previous Article
- Table of Contents
- Next Article
We use cookies to track usage and preferences.I Understand
Article metrics loading...
Full text loading...
CD44 as the Target Site for Hyaluronic Acid in Favor of Colitis Management, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/lddd/21/12/s2-1.gif